ICCM insider trading
NasdaqCM HealthcareIceCure Medical Ltd.: insider trade history from SEC Form 4 filings.
About IceCure Medical Ltd.
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
Company website: www.icecure-medical.com
ICCM insider activity at a glance
FilingIQ tracks 5 insider transactions for ICCM in filings since Aug 17, 2026. The most recent transaction is dated Aug 14, 2026.
Across the full history, 0 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
Latest ICCM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ICCM?
- FilingIQ tracks 5 Form 4 insider transactions for ICCM (IceCure Medical Ltd.), covering filings from Aug 17, 2026 onwards. 5 of those are dated within the last 90 days.
- Are ICCM insiders net buyers or net sellers?
- Across the full Form 4 history for ICCM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ICCM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ICCM in?
- IceCure Medical Ltd. (ICCM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $11.41M.
Methodology & sources
Every ICCM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.